| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; CHEN-HUA LIU ; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. | Scientific Reports | |||
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN ; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. | Scientific Reports | |||
| 2016 | Combined interactions of plant homeodomain and chromodomain regulate NuA4 activity at DNA double-strand breaks | Su W.-P.; Hsu S.-H.; Chia L.-C.; Lin J.-Y.; Chang S.-B.; Jiang Z.-D.; Lin Y.-J.; Shih M.-Y.; Chen Y.-C.; Chang M.-S.; Yang W.-B.; Hung J.-J.; Hung P.-C.; Wu W.-S.; Myung K.; Liaw H.; MAU-SUN CHANG | Genetics | |||
| 2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Scientific Reports | |||
| 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG ; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. | International Journal of Cancer | |||
| 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | Shih J.-Y.; Gow C.-H.; CHONG-JEN YU ; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. | International Journal of Cancer | |||
| 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | JIN-YUAN SHIH ; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. | International Journal of Cancer | |||
| 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; PAN-CHYR YANG | International Journal of Cancer | |||
| 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; PAN-CHYR YANG | International Journal of Cancer | |||
| 2006 | Functional MR imaging of tumor angiogenesis predicts outcome of patients with acute myeloid leukemia [5] | TIFFANY TING-FANG SHIH ; Tien H.-F.; Liu C.-Y.; Su W.-P.; Chan W.-K.; Yang P.-C. | Leukemia | |||
| 2006 | Functional MR imaging of tumor angiogenesis predicts outcome of patients with acute myeloid leukemia [5] | Shih T.T.-F.; Tien H.-F.; Liu C.-Y.; Su W.-P.; Chan W.-K.; PAN-CHYR YANG | Leukemia | |||
| 2006 | Functional MR imaging of tumor angiogenesis predicts outcome of patients with acute myeloid leukemia [5] | Shih T.T.-F.; HWEI-FANG TIEN ; Liu C.-Y.; Su W.-P.; Chan W.-K.; Yang P.-C. | Leukemia | |||
| 2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chiun Hsu ; Yang P.-C. | Journal of the Formosan Medical Association | |||
| 2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; Yang C.-H.; CHONG-JEN YU ; Shih J.-Y.; Hsu C.; Yang P.-C. | Journal of the Formosan Medical Association | |||
| 2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH ; Hsu C.; Yang P.-C. | Journal of the Formosan Medical Association | |||
| 2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Hsu C.; PAN-CHYR YANG | Journal of the Formosan Medical Association | |||
| 2005 | Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients | Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J. | World Journal of Gastroenterology | |||
| 2005 | Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients | Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J. | World Journal of Gastroenterology | |||
| 2014 | A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies | Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU ; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. | British Journal of Cancer | |||
| 2014 | Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer | Wang C.-Y.; Chao T.-T.; Tai W.-T.; Chang F.-Y.; Su W.-P.; Chen Y.-L.; Chen P.-T.; Weng C.-Y.; ANG YUAN ; Shiau C.-W.; Yu C.-J.; Chen K.-F. | Journal of Thoracic Oncology |
